Goldman Sachs’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-90,969
| Closed | -$97K | – | 5968 |
|
2022
Q1 | $97K | Buy |
90,969
+3,044
| +3% | +$3.25K | ﹤0.01% | 5325 |
|
2021
Q4 | $167K | Sell |
87,925
-22,931
| -21% | -$43.6K | ﹤0.01% | 5057 |
|
2021
Q3 | $334K | Buy |
110,856
+42,069
| +61% | +$127K | ﹤0.01% | 4600 |
|
2021
Q2 | $269K | Sell |
68,787
-3,086
| -4% | -$12.1K | ﹤0.01% | 4759 |
|
2021
Q1 | $365K | Buy |
+71,873
| New | +$365K | ﹤0.01% | 4538 |
|
2020
Q4 | – | Sell |
-17,640
| Closed | -$86K | – | 4814 |
|
2020
Q3 | $86K | Buy |
+17,640
| New | +$86K | ﹤0.01% | 4254 |
|
2020
Q2 | – | Sell |
-42,786
| Closed | -$140K | – | 4618 |
|
2020
Q1 | $140K | Buy |
+42,786
| New | +$140K | ﹤0.01% | 4079 |
|
2018
Q3 | – | Sell |
-60,142
| Closed | -$223K | – | 4286 |
|
2018
Q2 | $223K | Buy |
+60,142
| New | +$223K | ﹤0.01% | 3846 |
|
2017
Q3 | – | Sell |
-143,606
| Closed | -$732K | – | 4469 |
|
2017
Q2 | $732K | Buy |
143,606
+131,439
| +1,080% | +$670K | ﹤0.01% | 3311 |
|
2017
Q1 | $84K | Sell |
12,167
-48,315
| -80% | -$334K | ﹤0.01% | 4150 |
|
2016
Q4 | $566K | Sell |
60,482
-2,268
| -4% | -$21.2K | ﹤0.01% | 3378 |
|
2016
Q3 | $614K | Buy |
62,750
+11,882
| +23% | +$116K | ﹤0.01% | 3319 |
|
2016
Q2 | $719K | Buy |
50,868
+14,357
| +39% | +$203K | ﹤0.01% | 3131 |
|
2016
Q1 | $510K | Buy |
+36,511
| New | +$510K | ﹤0.01% | 3212 |
|
2015
Q2 | – | Sell |
-23,146
| Closed | -$463K | – | 4779 |
|
2015
Q1 | $463K | Sell |
23,146
-45,624
| -66% | -$913K | ﹤0.01% | 3362 |
|
2014
Q4 | $1.45M | Buy |
+68,770
| New | +$1.45M | ﹤0.01% | 2703 |
|
2014
Q3 | – | Sell |
-12,714
| Closed | -$294K | – | 4638 |
|
2014
Q2 | $294K | Buy |
+12,714
| New | +$294K | ﹤0.01% | 3712 |
|